Cancer Stem Cells Aren’t “Roots”: The Plasticity Model Explained cover art

Cancer Stem Cells Aren’t “Roots”: The Plasticity Model Explained

Cancer Stem Cells Aren’t “Roots”: The Plasticity Model Explained

Listen for free

View show details

About this listen

 📬 Join Dr. Goodyear’s Newsletter ➡️ https://pre-scribed.com/subscribe/ Episode Overview: Cancer stem cells (CSCs) aren’t “fixed roots” you can yank out—they’re shape-shifters. In this solo deep dive, Dr. Nathan Goodyear, MD, MDH, ABAARM, breaks down the pivot from the old rigid tumor hierarchy model to today’s plasticity paradigm, showing how CSCs dynamically reprogram in response to microenvironmental cues and treatment pressure. He maps the evidence timeline (1997 → 2025), explains why the “magic bullet” fails, and outlines multi-axis strategies that target both CSC identities and the reprogramming circuits that let tumors adapt. This isn’t just a conversation—it’s a call to action. 📌 Key Takeaways From fixed to flexible: The field has shifted from a rare, static CSC “root” to dynamic, reprogrammable states across a spectrum. Microenvironment matters: Hypoxia, acidity, immune cells, cytokines (e.g., TGF-β, IL-6) and stromal players drive CSC plasticity; target the neighborhood, not just the “seed.” Therapy pressure reshapes tumors: Surgery, chemo, radiation can unintentionally induce CSC traits, fueling resistance, recurrence, and metastasis. Epigenetic—not just genetic: Rapid phenotypic switching is powered by epigenetic rewiring (transcriptomic/proteomic/metabolic shifts), not necessarily mutations. Parallels across immunity: Macrophages (M1/M2), neutrophils (N1/N2), T cell effector↔regulatory toggling mirror CSC plasticity—biology favors state transitions. EMT ↔ MET as a lever: Epithelial–mesenchymal transitions promote motility, stemness, and therapy escape; reverse transitions enable colonization. Markers aren’t destiny: CSC markers (CD133, CD44, ALDH activity) are heterogeneous and context-dependent; no single marker defines CSCs across cancers. Why “target the root” fails: Eliminate one pool (e.g., LGR5⁺) and redundant or oncofetal programs compensate; blocking reprogramming is essential. Clinical framing: Reimagine cancer as an adaptive ecosystem; use combination/stacked strategies (standard of care + plasticity inhibitors / microenvironmental mods). Actionable shift: Build protocols that measure and modulate inflammation and immune signaling while avoiding one-size-fits-all dosing (precision IV vitamin C is one example of dosing by PK/PD realities). ⏱️ Timestamps 00:00:37 – Cancer stem cells: setting the stage 00:02:12 – CSCs as shape-shifters: plasticity over hierarchy 00:04:08 – Evidence timeline (1997→2025): from hierarchy to plasticity 00:08:03 – The fixed hierarchy model (roots & branches) 00:09:35 – Tumor microenvironment & therapy pressures 00:10:29 – Epigenetic reprogramming & real-time phenotypic switching 00:12:16 – Bidirectional state shifts (CSC ↔ non-CSC; EMT/MET) 00:14:16 – Immune cell plasticity parallels (M1/M2, N1/N2) 00:16:36 – T-cell plasticity: effector ↔ regulatory toggling 00:20:47 – Therapeutic implications: fixed vs plasticity-informed strategies 00:24:34 – CSC markers & caveats (CD133, CD44, ALDH; heterogeneity) 00:27:42 – Beyond the magic bullet: cancer as adaptive ecosystem 00:36:59 – How surgery/chemo/radiation induce CSC traits 00:43:05 – New consensus & multi-axis treatment playbook 🔔 Subscribe for more evidence-based conversations on the future of functional medicine. 📚 Resources & Links: Chosen research thread (ResearchRabbit collection): https://www.researchrabbitapp.com/collection/public/0LJGWQ9PLW Key citations (APA): Dvorak, H. F. (1986). Tumors: Wounds that do not heal. New England Journal of Medicine, 315(26), 1650–1659. Mzoughi, S., Heuberger, J., Schaefer, S. M., Sahu, P., Berger, A. K., … Clevers, H. (2025). Oncofetal reprogramming drives phenotypic plasticity in WNT-driven colorectal cancer. Nature Genetics, 57(2), 299–311. https://doi.org/10.1038/s41588-024-02058 Chaffer, C. L., et al. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. PNAS, 108(19), 7950–7955. Gupta, P. B., et al. (2009). Stochastic state transitions give rise to phenotypic equilibrium in cancer cell populations. Cell. ▶️ Watch more episodes + full show notes: https://prescribedpodcast.com 🧬 Dr. Nathan Goodyear’s work: https://www.drgoodyear.com 📚 Learn more about integrative oncology: https://pre-scribed.com 📞 Schedule a consultation or learn more: https://williamscancerinstitute.com Clinic & Socials Links: 🏥 Visit Dr. Goodyear’s clinic: https://www.drgoodyear.com 📸 Follow us on Socials: https://linktr.ee/doctornathangoodyear
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.